intraocular malignant lymphoma
Conditions
Interventions
Injection of 400 ug of methotrexate into a vitreous cabity twice a week for 1 month as introduction therapy, once a week for 1 month as reinforcement therapy, and once a month for 1 year as maintenan
Sponsors
Yamaguchi university hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) patients that has a malignant lymphoma , have choroid infiltrate and vitreal opacity and isn't effectual for radiotherapy. 2) more than 20 years old, less than 90 years old in the time of the agreement 3) male and female 4) informed consented patients 5) hospitalizing and foreignness
Exclusion criteria
Exclusion criteria: 1) the patient an overlap of other retina vitreous diseases fixes or doubts 2) the patient who can't have a doubtful point in a fixation check and get consent between the medical specialist 3) the patient who participated in a clinical clinical trial within 3 months of sample extraction 4) the patient who allowed a study responsibility doctor to be unsuitable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of improvement of the clinical presentation. | — |
Countries
Japan
Contacts
Public ContactKazuhiro Kimura
Yamaguchi university hospital ophthalmology
Outcome results
None listed